This product is for research use only, not for human use. We do not sell to patients.
Size | Price | Stock |
---|---|---|
250mg | $750 | Check With Us |
500mg | $1250 | Check With Us |
1g | $1875 | Check With Us |
Cat #: V3676 CAS #: 1268524-71-5 Purity ≥ 98%
Description: (-)-JQ-1 is the (R)-Enantiomer of JQ1 or the stereoisomer of (+)-JQ1.
References: Filippakopoulos, et al. Selective inhibition of BET bromodomains. Nature. 2010 Dec 23;468(7327):1067-73.
Publications Citing InvivoChem Products
Product Promise
- Physicochemical and Storage Information
- Protocol
- Related Biological Data
- Stock Solution Preparation
- Quality Control Documentation
Molecular Weight (MW) | 456.99 |
---|---|
Molecular Formula | C23H25ClN4O2S |
CAS No. | 1268524-71-5 |
Storage | -20℃ for 3 years in powder formr |
-80℃ for 2 years in solvent | |
Solubility In Vitro | DMSO: 91 mg/mL (199.1 mM)r |
Water: <1 mg/mLr | |
Ethanol: 91 mg/mL (199.1 mM) | |
Solubility In Vivo | 2% DMSO+30% PEG 300+5% Tween 80+ddH2O: 5 mg/mL |
SMILES Code | O=C(C[C@H]1N=C(C2=C(N3C1=NN=C3C)SC(C)=C2C)C4=CC=C(C=C4)Cl)OC(C)(C)C |
Synonyms | Bromodomain Inhibitor; (-)-JQ-1; (1)-JQ1; (1)-JQ 1; (R)-(-)-JQ1 Enantiomer |
Protocol | In Vitro | (R)-(-)-JQ1 Enantiomer shows no significant interaction with any bromodomain. Besides, (R)-(-)-JQ1 Enantiomer is comparatively inactive in nuclear protein in testis (NUT) midline carcinoma (NMC). |
---|
Solvent volume to be added | Mass (the weight of a compound) | |||
---|---|---|---|---|
Mother liquor concentration | 1mg | 5mg | 10mg | 20mg |
1mM | 2.1882 mL | 10.9412 mL | 21.8823 mL | 43.7646 mL |
5mM | 0.4376 mL | 2.1882 mL | 4.3765 mL | 8.7529 mL |
10mM | 0.2188 mL | 1.0941 mL | 2.1882 mL | 4.3765 mL |
20mM | 0.1094 mL | 0.5471 mL | 1.0941 mL | 2.1882 mL |
This equation is commonly abbreviated as: C1 V1 = C2 V2
- (1) Please be sure that the solution is clear before the addition of next solvent. Dissolution methods like vortex, ultrasound or warming and heat may be used to aid dissolving.
- (2) Be sure to add the solvent(s) in order.